<DOC>
	<DOC>NCT02125825</DOC>
	<brief_summary>The objective is to assess a compact, portable, wireless movement disorder system with continuous monitoring capabilities to detect and quantify the severity of levodopa-induced dyskinesia in Parkinson's disease.</brief_summary>
	<brief_title>Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Diagnosis of idiopathic Parkinson's disease Clinical history of levodopainduced dyskinesia 21 Years of age or older Stage 2 4 OFFmedication on the Hoehn and Yahr scale Dementia (determined by a neuropsychological assessment) Severe tremor unaffected by levodopa</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>